QQ客服 官方微博 反馈留言

浏览/检索结果: 共8条，第1-8条 帮助 限定条件 发表日期：2021     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序提交时间升序提交时间降序题名升序题名降序作者升序作者降序 Pyrotinib plus capecitabine for HER2-positive metastatic breast cancer patients with brain metastases (PERMEATE): A multicenter, single-arm phase II study. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者:  Yan, Min;  Ouyang, Quchang;  Sun, Tao;  Niu, Limin;  Yang, Jin 收藏  |  浏览/下载：12/0  |  提交时间：2022/01/10 Efficacy of everolimus-containing chemotherapy in HER2 negative metastatic breast cancer patients with PI3K/AKT/mTOR mutations: A retrospective study. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者:  Wang, Rong;  Wang, Xiaojia;  Chen, Zhan-Hong;  Niu, Jin;  Huang, Yuan 收藏  |  浏览/下载：11/0  |  提交时间：2022/01/10 Exploring the concepts and practices of advanced breast cancer treatment: a narrative review 期刊论文 ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9 作者:  Wang, Xiaojia;  Shao, Xiying;  Huang, Jian;  Lei, Lei;  Huang, Yuan 收藏  |  浏览/下载：38/0  |  提交时间：2021/06/15 Metastatic breast cancer (MBC)  treatment  cure  molecular types  targeted therapy   Ki67 and progesterone receptor status predicts sensitivity to palbociclib: a real-world study 期刊论文 ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9 作者:  Shao, Xiying;  Zheng, Yabing;  Cao, Wenming;  Shen, Xiabo;  Li, Guangliang 收藏  |  浏览/下载：48/0  |  提交时间：2021/06/15 Ki67  progesterone receptor  palbociclib   Case Report: Significant Response to Immune Checkpoint Inhibitor Camrelizumab in a Heavily Pretreated Advanced ER+/HER2-Breast Cancer Patient With High Tumor Mutational Burden 期刊论文 FRONTIERS IN ONCOLOGY, 2021, 卷号: 10 作者:  Wang, Rong;  Yang, Yuchen;  Ye, Wei-Wu;  Xiang, Jianxing;  Chen, Songan 收藏  |  浏览/下载：43/0  |  提交时间：2021/04/26 breast cancer  immunotherapy  biomarker  TMB  NGS  molecular monitoring   Primary analysis of OVERSTEP: A multicenter, randomized clinical trial of capecitabine or endocrine therapy as a maintenance therapy after the 1st-line chemotherapy in hormone receptor positive and HER2-negative advanced/metastatic breast cancer 期刊论文 CANCER RESEARCH, 2021, 卷号: 81 作者:  Huang, Jian;  Shao, Xiying;  Cai, Li;  Shi, Yanxia;  Chen, Zhanhong 收藏  |  浏览/下载：28/0  |  提交时间：2021/04/26 The association of CMTM6 expression with prognosis and PD-L1 expression in triple-negative breast cancer 期刊论文 ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9 作者:  Tian, Yiping;  Sun, Xiaohui;  Cheng, Guoping;  Ji, Enming;  Yang, Shifeng 收藏  |  浏览/下载：32/0  |  提交时间：2021/05/17 CMTM6  PD-L1  triple-negative breast cancer (TNBC)  immunohistochemistry (IHC)  polymerase chain reaction (PCR)  prognosis   CST6 protein and peptides inhibit breast cancer bone metastasis by suppressing CTSB activity and osteoclastogenesis 期刊论文 THERANOSTICS, 2021, 卷号: 11, 期号: 20, 页码: 9821-9832 作者:  Li, Xiaoxun;  Liang, Yajun;  Lian, Cheng;  Peng, Fangli;  Xiao, Yansen 收藏  |  浏览/下载：23/0  |  提交时间：2022/01/04 Breast cancer  Bone metastasis  Osteoclastogenesis  CST6  Peptide drug